Tag: importation

06 Feb 2017
img

Today, Prescription Justice issued a press release announcing new data showing that 45 million Americans did not fill a prescription in 2016 because of drug costs and the publication of its policy report recommending that President Donald Trump take executive actions to help consumers more easily import lower cost medications for personal use. Previously, Prescription Justice reported that 35 million American adults did not fill a prescription because of cost. The new data, extracted from the Commonwealth Fund’s 2016 International Health Policy Survey of Adults, shows the crisis of high drug prices to be worse than is widely reported. (more…)

30 Jan 2017
img

We are proud to announce that we have changed our organization's (DBA) name from Prescription Justice Action Group to Prescription Justice, which is a simpler expression of our core position: making prescription drugs affordable is an issue of justice for Americans and we will help them obtain it.

In addition to our website and logo redesign, we have also added a weekly media update that features top news and journal articles focused on our policy priorities - personal drug importation, Medicare Drug Price Negotiations, and ending "Pay for Delay", - as well as other advocacy efforts about tackling the prescription drug price crisis in America and globally.

Let's all work together to bring about prescription justice!

21 Jan 2017
img

Last week, Senators Bernie Sanders (I-VT) and Amy Klobuchar (D-MN) proposed an amendment (S.A. 178) to the Senate Budget Reconciliation bill that would allow individuals, pharmacies and wholesalers to import prescription medications from Canada and other countries with a valid prescription from a U.S. provider.

The amendment took place during a 7-hour vote-a-rama in which more than 150 amendments were considered and voted on for a brief ten minutes.  The amendment failed 52-46, with 13 Democrats voting against it. While the measure failed to pass, it surprisingly garnered support from 12 Republicans including Senators Ted Cruz and Rand Paul. It’s worth noting that Senators Chuck Schumer (D-NY) and Kristen Gillibrand (D-NY) voted against the Dorgan-Snowe importation amendment in 2009, voted yes this time around. (more…)

17 Nov 2016
img

Last year, U.S. spending on prescription drugs was at a record breaking $425 billion before discounts, and is expected to rise by 22% annually over the next five years, which is  400%, or over $600 billion by 2020. As Donald Trump is sworn in as the 45th president of the United States, Americans across the country concerned with the soaring costs of prescription medications, will be looking to President Trump and Congress for solutions to address this national crisis.

President-Elect Trump’s top priority for healthcare reform is to repeal the Affordable Care Act, but most Americans are more concerned about prescription drug prices than Obamacare. A recent Kaiser Health Tracking Poll found that nearly 74 percent of Americans agree that a top priority for the next president and Congress should be to ensure that drugs for chronic health conditions are affordable for patients. Additionally, 63 percent believe that the federal government’s top priority should be to lower the cost of prescription medications. Last week, President-Elect Trump released a brief healthcare plan on his transition website. While the newest healthcare plan does not include prescription drug pricing, during the campaign Mr. Trump declared support for allowing Americans to import lower cost medications as part of his 7-point healthcare plan.  Although not noted on that plan, President-Elect Trump voiced support for Medicare drug price negotiations during his campaign.

(more…)

01 Nov 2016
img

Part of a series of posts about common chronic illnesses and what happens when people cannot afford prescription medications to treat them.

Hepatitis C is an infection caused by a virus that attacks the liver and causes inflammation.  An estimated 3.5 million Americans are living with hepatitis C, with about half unaware they even have it. Recent advancements in hepatitis C treatments have greatly improved. New medications can lead to a cure in about 90 percent of people. But the prices for such treatments are prohibiting access and that means more people will remain sick and sometimes die. The Centers for Disease Control and Prevention found that in 2014, hepatitis C related deaths reached an all-time high of 19,659, killing more Americans each year than all other infectious diseases combined, including HIV.

(more…)

19 Oct 2016
img

 

A large share of medication that is imported by Americans for personal use from Canada and many other countries is ordered on the Internet. It’s not a secret that the pharmaceutical industry, U.S. chain pharmacies and the U.S Food and Drug Administration are not happy about it. But what they are doing about it is less well-known and even less well-understood. An important article published by Jeremy Malcolm of the Electronic Frontier Foundation last week called “How Big Pharma’s Shadow Regulation Censors the Internet” brings the situation into clear view. Multinational pharmaceutical companies and the FDA are funding non-profit groups, global initiatives, or private companies, ones that all work with each other, to make it harder, and may make it impossible, for Americans to buy medications online for personal import.

The ‘censorship’ about which Mr. Malcolm writes is subtle but no less real than more overt censorship. The censors essentially would like all international online pharmacies that sell to consumers in the U.S. to be shutdown. For the millions of Americans who can’t or struggle to afford medication, those websites are a lifeline and that censorship, if successful, would end it.

(more…)

29 Sep 2016
img

Part of a series of posts about common chronic illnesses and what happens when people cannot afford prescription medications to treat them.

Americans are dying from cancer because they either can’t afford the medications to treat it, or they have the money but refuse to bankrupt their families. Cancer is the second leading cause of death after heart disease in the U.S., claiming more than half a million lives each year. In 2016, it is estimated that 1,685,210 new cases of cancer will be diagnosed in the U.S., amounting to one new diagnosis every 30 seconds.

(more…)

08 Jul 2016
The Personal Drug Importation Fairness Act
img

About four million Americans import medication for personal use each year because of high drug costs, according to the U.S. Centers of Disease Control and Prevention. Their actions, under most circumstances, are technically illegal, but not something over which the government prosecutes individuals. The law, however, is unjust and unfair and should be reformed so that people who buy medication from a pharmacy in a different country are not, technically, criminally liable. Think about it. The medication you take is 90% cheaper in a different country and you can’t afford it domestically. It’s available for import by mail from a licensed pharmacy that you can access on the Internet. Why should the act of importing it be illegal?

The Personal Drug Importation Fairness Act of 2015 (PDIFA), H.R. 2623, expressly legalizes the importation and Reimportation for personal use of medications. Its passage would make it expressly legal to order a medication online and have it imported for personal use or simply bring it back into the U.S. by car or plane. The bill was introduced by Congressman Keith Ellison in June of 2015, and is cosponsored by Congressman Dana Rohrabacher (R-CA), Congresswoman Janice Schakowsky (D-IL), Congresswoman Raul Grijalva (D-AZ), Congressman Alcee Hastings (D-FL), Congressman Jerrold Nadler (D-NY), Congressman Collin Peterson (D-MN), and Congresswoman Rosa DeLauro (D-CT).

(more…)

19 Nov 2015
img

Prescription Justice Action Group (PJAG), a new non-profit organization, is here to help bring justice to American consumers who are literally sick from the high cost of prescription medication. New federal regulations and other actions by the government and pharmaceutical industry, particularly toward online pharmacies, threaten access to safe and affordable imported medication. PJAG recently formed to coordinate a response to these developments and to advocate for policies to bring down drug prices here at home.

Its Board of Directors supports new laws and regulations to lower drug prices in the U.S. and opposes current laws and regulations that obstruct access to safe and affordable medication, both domestic and foreign.

(more…)